SCHEMBL7060431

SCHEMBL7060431

COc1ccc(-c2cc3nccc(S(=O)(=O)c4ccccc4)c3[nH]2)c(C=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 4/20 0.47
KDM5A P29375 3/20 0.47
KDM5B Q9UGL1 3/20 0.47
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
HSP90AA1 P07900 1/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CES2 O00748 1/20 0.38
KDM4E B2RXH2 3/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
FEN1 P39748 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
MAPK1 P28482 1/20 0.35
CNR2 P34972 1/20 0.35
JAK2 O60674 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608317 0.74 PDE2A (0.44) KDM4CKDM5AKDM5BALDH1A1MAPT
SCHEMBL20125301 0.73 KDM4C (0.67) KDM4CKDM5AKDM5BALDH1A1HPGD
SCHEMBL16495095 0.73 GAA (0.51) ALDH1A1HPGDMAPTLMNAHSP90AA1
SCHEMBL7062780 0.72 HSD11B1 (0.48) KDM4CKDM5AKDM5BALDH1A1MAPT
SCHEMBL28517488 0.68 ERN1 (0.54) ALDH1A1HPGDMAPTLMNAKDM4E
SCHEMBL7066067 0.67 KDM4E (0.57) ALDH1A1HPGDMAPTLMNAKDM4E
SCHEMBL27003021 0.65 PIK3CA (0.49) ALDH1A1HPGDMAPTLMNAHSP90AA1
SCHEMBL16149595 0.64 KDM4C (1.00) KDM4CKDM5AKDM5BLMNA
SCHEMBL7060435 0.64 KDM4C (0.46) KDM4CKDM5AKDM5BALDH1A1MAPT
SCHEMBL28732809 0.64 ERN1 (0.46) ALDH1A1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030158216-A1 2-acyl indole derivatives and their use as antitumor agents BAXTER ONCOLOGY GMBH 2003-08-21 US disclosed
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents BECKERS THOMAS (DE) 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158216-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT KDM4C 3331/4885KDM5A 1677/4885KDM5B 2242/4885
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT KDM4C 3331/4885KDM5A 1677/4885KDM5B 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.